Logo

Beckman Coulter Closes $600M Offering of Convertible Notes

Dec 18, 2006
NEW YORK (GenomeWeb News) - Beckman Coulter said it is closing its offering of $600 million in convertible senior notes that it announced last week.
 
The company said the closing satisfied one condition of the offer, which allowed for the sale of notes that pay 2.5 percent semiannually and occasionally at the beginning of a six-month period December 2012, and are due in 2036.
 
Beckman offered an initial $525 million and investors took a $75 million option, the company said.
 
The tender offering closes Tuesday, December 19 at 5:00 EST, unless the company announces otherwise.
 
Beckman said it will use the part of the cash to resolve outstanding debts and fund R&D efforts, including a molecular diagnostics project.  
Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.